Lundberg Sven Ante

Director at VOR

Sold, on record
None
Dollars the filings state
Form 4 sales
0
None on record
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • VORVor Biopharma Inc.Director

Sales by reason

No Form 4 sale on record for Lundberg Sven Ante.

Timeline

  1. Aug 4, 2025Notice

    VOR

    Filed a notice to sell 29,432 shares

    $62k29,432 shares

    Filed Aug 4, 2025Form 144

1 of 1

Every transaction

Every transaction on a Form 4 or Form 5 by Lundberg Sven Ante
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 12, 2026Jun 16, 2026QTTBDirectorAwardedStock Option (Right to Buy)9,8109,810SEC
Jan 15, 2026Jan 30, 2026QTTBDirectorAwardedStock Option (Right to Buy)20,363$2.75$56k20,363SEC
Dec 12, 2025Dec 12, 2025Merus N.V.President, CEO & PEOTendered83,435$97.00$8.1M0SEC
Dec 12, 2025Dec 12, 2025Merus N.V.President, CEO & PEOReturned to the companyShare Option (right to buy)2M0SEC
Nov 25, 2025Nov 28, 2025Merus N.V.President, CEO & PEOGift196,2099,192SEC
Oct 23, 2025Oct 27, 2025QTTBDirectorAwardedStock Option (Right to Buy)53,52153,521SEC
May 22, 2025May 23, 2025VORDirectorAwardedStock Option (Right to Buy)30,00030,000SEC
Apr 17, 2025Apr 21, 2025Merus N.V.President, CEO & PEOExercised or settledShare Option (right to buy)30,297$13.40$406k312,620SEC
Apr 17, 2025Apr 21, 2025Merus N.V.President, CEO & PEOExercised options30,297$13.40$406k30,297SEC
Feb 24, 2025Feb 26, 2025QTTBDirectorReturned to the companyStock Option (Right to Buy)48,3540SEC
Feb 24, 2025Feb 26, 2025QTTBDirectorAwardedStock Option (Right to Buy)70,17823,140SEC
Feb 19, 2025Feb 21, 2025Merus N.V.President, CEO & PEOGift81,20240,601SEC
Feb 13, 2025Feb 18, 2025Merus N.V.President, CEO & PEOExercised or settledShare Option (right to buy)16,372351,628SEC
Feb 13, 2025Feb 18, 2025Merus N.V.President, CEO & PEOExercised options16,372$24.43$400k40,601SEC
Jan 29, 2025Jan 31, 2025Merus N.V.President, CEO & PEOAwardedShare Option (right to buy)300,000300,000SEC
Sep 25, 2024Sep 27, 2024QTTBDirectorAwardedStock Option (Right to Buy)1,3161,316SEC
May 23, 2024May 28, 2024VORDirectorAwardedStock Option (Right to Buy)30,00030,000SEC
May 7, 2024May 9, 2024Merus N.V.President, CEO & PEOAwardedShare Option (right to buy)360,000360,000SEC
Mar 25, 2024Mar 27, 2024QTTBDirectorAwardedStock Option (Right to Buy)12,76712,767SEC
May 26, 2023Jun 2, 2023VORDirectorAwardedStock Option (right to buy)30,00030,000SEC
Feb 2, 2023Feb 3, 2023Merus N.V.President, CEO & PFOAwardedShare Option (right to buy)380,000380,000SEC
Nov 3, 2022Nov 3, 2022Merus N.V.President, CEO & PFOBought14,706$14.38$211k40,576SEC
Aug 22, 2022Aug 23, 2022Merus N.V.President, CEO & PFOBought5,826$22.92$134k25,870SEC
Aug 19, 2022Aug 22, 2022Merus N.V.President, CEO & PFOBought704$22.99$16k20,044SEC
Jul 12, 2022Jul 13, 2022Merus N.V.President, CEO & PFOBought4,340$22.97$100k19,340SEC
Jun 14, 2022Jun 16, 2022VORDirectorAwardedStock Option (right to buy)16,91116,911SEC
Jan 31, 2022Feb 2, 2022Merus N.V.President, CEO & PFOAwardedShare Option (right to buy)295,000295,000SEC
Aug 2, 2021Aug 4, 2021Merus N.V.President, CEO & PFOExercised or settledShare Option (right to buy)15,000$13.36$200k339,120SEC
Aug 2, 2021Aug 4, 2021Merus N.V.President, CEO & PFOExercised options15,000$13.36$200k15,000SEC
Mar 25, 2021Mar 29, 2021Merus N.V.President, CEO & PFOGift74,0000SEC
Mar 1, 2021Mar 3, 2021Merus N.V.President, CEO & PFOExercised or settledShare Option (right to buy)74,000351,747SEC
Mar 1, 2021Mar 3, 2021Merus N.V.President, CEO & PFOExercised options74,000$13.38$990k74,000SEC
Feb 16, 2021Feb 18, 2021Merus N.V.President, CEO & PFOAwardedShare Option (right to buy)368,000368,000SEC
Feb 5, 2021Feb 9, 2021VORDirectorAwardedStock Option (right to buy)16,90016,900SEC
Jan 3, 2020Jan 6, 2020Merus N.V.President, CEO & PFOAwardedShare Option (right to buy)414,917414,917SEC
Oct 24, 2016Feb 10, 2017CRSPChief Scientific OfficerBought400$14.00$6k505,617SEC
Oct 24, 2016Feb 10, 2017CRSPChief Scientific OfficerConvertedSeries B Preferred Shares55,2170SEC
Oct 24, 2016Feb 10, 2017CRSPChief Scientific OfficerConverted55,217505,217SEC

Sales and notices (1)

Form 144 notices and Form 4 sales by Lundberg Sven Ante
Source
Aug 4, 2025Aug 4, 2025VORDirectorForm 144 notice29,432$62kNoticeSEC